Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

884
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
884
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.3K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

5.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.8K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pressure ulcer following compression otoplasty garment: A rare but severe case report].

Annales de chirurgie plastique et esthetique·2026
Same author

[Fasciitis-like primary breast pyoderma gangrenosum: A rare case report].

Annales de chirurgie plastique et esthetique·2026
Same author

Declining research interest among oncology residents: insights into the academic career from a nationwide longitudinal study in France.

ESMO open·2026
Same author

Applied multivariate statistical analysis and geochemical modeling for assessing groundwater reactions in the multilayered São Sebastião-Marizal Aquifer System, Brazil.

The Science of the total environment·2025
Same author

Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study.

ESMO open·2025
Same author

Search for Highly Ionizing Particles in pp Collisions during LHC Run 2 Using the Full MoEDAL Detector.

Physical review letters·2025

Related Experiment Video

Updated: Mar 11, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

Focus on cannabinoids and synthetic cannabinoids.

R Le Boisselier1,2, J Alexandre2,3, V Lelong-Boulouard2,4

  • 1University Hospital Centre Côte de Nacre, Centre for Evaluation and Information on Pharmacodependance - Addictovigilance (CEIP-A), F-14033, Caen, France.

Clinical Pharmacology and Therapeutics
|November 19, 2016
PubMed
Summary

Synthetic cannabinoids (SCs) offer potent effects but pose risks. While the endocannabinoid system is vital, SCs present severe side effects and addiction concerns, necessitating further research for therapeutic potential.

More Related Videos

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

621
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

7.1K

Related Experiment Videos

Last Updated: Mar 11, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

621
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

7.1K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Toxicology

Background:

  • The endocannabinoid system regulates numerous physiological processes.
  • Synthetic cannabinoids (SCs) are increasingly prevalent, with effects often exceeding those of natural cannabis.
  • Understanding SCs is crucial due to their complex interactions with cannabinoid receptors.

Purpose of the Study:

  • To review the emerging information on synthetic cannabinoids.
  • To explore the physiological roles of the endocannabinoid system.
  • To assess the risks and potential therapeutic value of SCs.

Main Methods:

  • Literature review of synthetic cannabinoid research.
  • Analysis of pharmacological data on cannabinoid receptor interactions.
  • Examination of clinical reports on cannabinoid poisoning and abuse.

Main Results:

  • SCs exhibit full agonist activity and higher affinity for cannabinoid receptors compared to cannabis.
  • Adverse effects, including neurological and cardiovascular issues, are more intense with SCs.
  • Severe outcomes and addiction potential are significant concerns with SC use.

Conclusions:

  • Synthetic cannabinoids present a dual profile of potent effects and significant risks.
  • The scientific community is actively researching SCs for both their dangers and potential therapeutic applications.
  • Further investigation is warranted to manage SC-related toxicity and explore cannabinoid therapeutics.